R&D
12 Questions with Dr Jay Shah
Dr Jay Shah is Chief Medical Officer of Aktiia. Dr Shah completed his …
29 April, 2024
18715 items found
News
J&J gets CHMP nod for Rybrevant in first-line lung cancer
Johnson & Johnson’s Rybrevant is on the brink of EU approval as a …
29 April, 2024
News
Pfizer offers warranty for new haemophilia B therapy Beqvez
Pfizer has said it will launch its just-approved haemophilia B gene …
29 April, 2024
News
Is pharma’s interest in orphan drugs waning?
For many years, orphan drugs for rare diseases have been a draw for …
29 April, 2024
R&D
Reuters Pharma USA 2024 – Meruno Perugini
Innovation in pharma comes in many forms, but at the end of the day …
26 April, 2024
Market Access
Deep Dive: Market Access 2024
In this edition of Deep Dive, Unpacking complex choreography in the …
26 April, 2024
News
Owlstone secures $6.5M for breath-based diagnostics for infectious disease
Owlstone Medical has secured a $5 million equity investment and …
26 April, 2024
Patients
Spotlight on kidney disease: Driving change for patients
Katherine Forbes, director of innovation and enterprise at Kidney …
26 April, 2024
News
ETH develops AI algorithm for drug discovery based on 3D protein surface
Chemists at ETH Zurich have developed a new computer process that …
26 April, 2024
News
Moderna banks on OpenAI to accelerate mRNA research
In an ambitious move, Moderna has teamed up with OpenAI, the …
26 April, 2024
R&D
Partner Content
9th Microbiome Movement Drug Development Summit
Back for its 9th consecutive year and gathering over 250 leaders in …
25 April, 2024
R&D
Is precision psychiatry possible?
Anyone who has taken a psychiatric medication knows that the status …
25 April, 2024
News
BMS, J&J challenges to Medicare negotiations are thrown out
In another setback for the pharma industry, a US federal judge has rejected a bid to overturn the Medicare pricing negotiation brought by Bristol-Myers Squibb and Johnson
Digital
Sponsored
Innovation as Strategy: Enabling life sciences of the future
Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.
Market Access
Deep Dive: Market Access 2024
In this edition of Deep Dive, Unpacking complex choreography in the biologics patent dance, Alexion examines the urgent need for accelerated access programmes for rare disease treatments, and Putna
Sales & Marketing
Sponsored
How doctors are interacting with content in 10 data trends
It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.
Oncology
Sponsored
Patient Centricity to Integration: Enhancing Cancer Outcomes
We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
R&D
Partner Content
15th World Bispecific Summit 2024
Radically Optimize Bi, Tri & Multispecific Antibodies to Enhance Target Discovery, Mechanistic Diversity & Clinical Translation to Maximize the Therapeutic Index & Enhance Combi
R&D
Partner Content
2nd ADC Toxicity Summit 2024
Improving Prediction & Translation of ADC Toxicities to Drive More Tolerable ADCs Successfully Into & Through Clinical Development
